These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2906394)

  • 21. SK&F 89124, a potent and selective agonist at prejunctional dopamine receptors.
    Hieble JP; Sulpizio AC; Sarau HM; Flaim KE; Blumberg AL; McCafferty JP; Zeid RL
    Fundam Clin Pharmacol; 1989; 3(6):621-42. PubMed ID: 2575569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526.
    Ohlstein EH; Zabko-Potapovich B; Berkowitz BA
    J Pharmacol Exp Ther; 1984 May; 229(2):433-9. PubMed ID: 6143817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nitrendipine (BAY e 5009), nifedipine, verapamil, phentolamine, papaverine, and minoxidil on contractions of isolated rabbit aortic smooth muscle.
    Towart R
    J Cardiovasc Pharmacol; 1982; 4(6):895-902. PubMed ID: 6185780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the antiarrhythmic activity of one N-substituted piperazine derivative of trans-2-amino-3-hydroxy-1, 2, 3, 4-tetrahydroanaphthalene.
    Staneva-Stoycheva D; Boyadjiev T; Raynova L; Mihaylova S; Tomov T
    Acta Physiol Pharmacol Bulg; 1979; 5(3):51-8. PubMed ID: 44072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postsynaptic dopamine DA1- and DA2-receptors in jejunal arteries of rabbits.
    Münch G; Raether A; Schöffel E; Illes P
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):468-71. PubMed ID: 1720848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
    Lokhandwala MF; Sabouni MH
    J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in renal blood flow in the rat during renal nerve stimulation: the effects of alphs-adrenergic blockers and a dopaminergic blocker [proceedings].
    Chapman BJ; Horn NM; Munday KA; Robertson MJ
    J Physiol; 1979 Jun; 291():64P-65P. PubMed ID: 39166
    [No Abstract]   [Full Text] [Related]  

  • 30. Aminotetralins as selective beta-adrenergic agonists.
    Ilhan M; Kitzen JM; Cannon JG; Long JP
    Eur J Pharmacol; 1977 Feb; 41(3):301-6. PubMed ID: 14012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous demonstration of the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN.
    Stoof JC; Horn AS; Mulder AH
    Brain Res; 1980 Aug; 196(1):276-81. PubMed ID: 7397528
    [No Abstract]   [Full Text] [Related]  

  • 32. Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution.
    Kohli JD; Goldberg LI; McDermed JD
    Eur J Pharmacol; 1982 Jul; 81(2):293-9. PubMed ID: 6126371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotransmission in pig renal artery: the actions of angiotensin II and dopamine.
    Ferguson DR; Randall MD
    Br J Pharmacol; 1989 Feb; 96(2):279-82. PubMed ID: 2538187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration.
    Cannon JG; Lee T; Goldman HD
    J Med Chem; 1977 Sep; 20(9):1111-6. PubMed ID: 562941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine receptors: structure-activity relationship of d-tubocurarine analogues.
    Nelson SH; Steinsland OS
    Eur J Pharmacol; 1985 Jan; 108(2):209-12. PubMed ID: 3979441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mode of action of tetrandrine on vascular smooth muscle.
    Hu WS; Pang XB; Wang Y; Hu CJ; Lü FH
    J Tradit Chin Med; 1983 Mar; 3(1):7-12. PubMed ID: 6553137
    [No Abstract]   [Full Text] [Related]  

  • 37. [Change in the reactions of isolated vascular segments under the action of hypotensive agents].
    Kulagina VP; Udel'nov MG
    Kardiologiia; 1978 Dec; 18(12):94-8. PubMed ID: 732089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and serotonin-like activity of 2-amino-5,8-dimethoxy-6-methyl-1,2-dihydronaphthalene.
    Kothari PJ; Hathaway BA; Nichols DE; Yim GK
    J Med Chem; 1981 Jul; 24(7):882-4. PubMed ID: 7277398
    [No Abstract]   [Full Text] [Related]  

  • 39. Alpha- and beta-blocking agents: pharmacology and properties.
    Prichard BN
    Cleve Clin J Med; 1991; 58(4):337-50. PubMed ID: 1679681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of novel alkylpiperazines as potential dopamine antagonists.
    Glennon RA; Salley JJ; Steinsland OS; Nelson S
    J Med Chem; 1981 Jun; 24(6):678-83. PubMed ID: 7252977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.